Skip to content

Clinical trials

Myelodysplastic Syndromes trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Country / region: New Zealand Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20151
20202
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting3
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group2
BeOne Medicines1
Gilead Sciences1
Novartis Pharmaceuticals1
Otsuka Australia Pharmaceutical Pty Ltd1
PedAL BCU, LLC1
Takeda1
The Canadian Blood and Marrow Transplant Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes9
Leukemia, Myeloid, Acute4
Leukemia, Myelomonocytic, Chronic3
Myeloproliferative Disorders3
Anemia, Refractory2
Anemia, Refractory, with Excess of Blasts2
Leukemia2
Leukemia, Myelomonocytic, Juvenile2
Myelodysplastic-Myeloproliferative Diseases2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.